unknown
Stage
About
Cellsonics is developing SimpleFlow™, an automated tissue dissociation system that converts solid tissue into single-cell suspensions while aiming to preserve native gene expression for downstream single-cell analysis.
Explore Cellsonics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.